Anti-vascular therapy: a new approach to cancer treatment
Author:
- 1 January 2000
- journal article
- Published by BMJ in Western Journal of Medicine
- Vol. 172 (1) , 39-42
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Complete Remission of Metastatic Cervical Cancer with the Angiogenesis Inhibitor TNP-470New England Journal of Medicine, 1998
- A secreted FGF-binding protein can serve as the angiogenic switch in human cancerNature Medicine, 1997
- Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis.1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Angiostatin induces and sustains dormancy of human primary tumors in miceNature Medicine, 1996
- Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1Science, 1994
- Elevated Levels of an Angiogenic Peptide, Basic Fibroblast Growth Factor, in the Urine of Patients With a Wide Spectrum of CancersJNCI: Journal of the National Cancer Institute, 1994
- Sequestration and Release of Basic Fibroblast Growth FactoraAnnals of the New York Academy of Sciences, 1991
- A HIGHLY CONSERVED VASCULAR-PERMEABILITY FACTOR SECRETED BY A VARIETY OF HUMAN AND RODENT TUMOR-CELL LINES1986
- Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation.1974